---
title: "Cantor Fitzgerald Remains a Buy on Mereo Biopharma Group Plc (MREO)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286558931.md"
description: "Cantor Fitzgerald has maintained a Buy rating on Mereo Biopharma Group Plc (MREO) with a price target of $3.00, while the shares closed at $0.25. Analyst Kristen Kluska has an average return of 25.7% and a 49.85% success rate. The analyst consensus for Mereo is Moderate Buy, with a price target consensus of $2.33, indicating an 847.15% upside. Needham also supports a Buy rating with a $3.00 target."
datetime: "2026-05-15T11:37:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286558931.md)
  - [en](https://longbridge.com/en/news/286558931.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286558931.md)
---

# Cantor Fitzgerald Remains a Buy on Mereo Biopharma Group Plc (MREO)

In a report released on May 12, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Mereo Biopharma Group Plc, with a price target of $3.00. The company’s shares closed yesterday at $0.25.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Kluska covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Soleno Therapeutics, and Capricor Therapeutics. According to TipRanks, Kluska has an average return of 25.7% and a 49.85% success rate on recommended stocks.

Mereo Biopharma Group Plc has an analyst consensus of Moderate Buy, with a price target consensus of $2.33, which is an 847.15% upside from current levels. In a report released on May 12, Needham also maintained a Buy rating on the stock with a $3.00 price target.

### Related Stocks

- [MREO.US](https://longbridge.com/en/quote/MREO.US.md)
- [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md)
- [SLNO.US](https://longbridge.com/en/quote/SLNO.US.md)
- [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md)

## Related News & Research

- [Mereo BioPharma Shareholders Approve All AGM Resolutions](https://longbridge.com/en/news/286435474.md)
- [Mereo Biopharma Group Plc (MREO) Receives a Buy from Leerink Partners](https://longbridge.com/en/news/271216337.md)
- [Stifel Nicolaus Sticks to Their Buy Rating for Target Hospitality (TH)](https://longbridge.com/en/news/286494923.md)
- [Do Wall Street Analysts Like Darden Restaurants Stock?](https://longbridge.com/en/news/286675237.md)
- [RBC Bearings Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/286525864.md)